NCT05871905View on ClinicalTrials.gov

[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

November 6, 2023

Study Completion Date

June 20, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

TY-9591

C14 TY-9591

Trial Locations (1)

Unknown

Suzhou first people's hospital, Suzhou

All Listed Sponsors
lead

TYK Medicines, Inc

INDUSTRY

NCT05871905 - [14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter